# RUBICON share price, delivery % and history — Rubicon Research Limited

> Delivery percentage for Rubicon Research Limited (RUBICON) against its own history, with 237 sessions of split-adjusted NSE data from 2025 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/RUBICON

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 1,619.4 INR (0.65% on the day), 2026-09-30
- Delivery: 60.9% of volume taken to demat (20-day average 53%)
- Volume: 2.28L shares, turnover ₹37.0Cr
- Relative volume: 0.84× of its own 20-day average

## Technicals

- RSI(14): 39.39
- ATR(14): 70.35
- SMA 50: 1,684.1, SMA 200: 1,114.96
- 52-week range: — – — (— from the high)

## Performance

- 1 week -3.31%, 1 month -11%, 3 months 17.84%
- 6 months 110.9%, 1 year —

## Delivery percentage

- Latest: 60.9% (2026-09-30)
- 20-day average: 53%
- 1-year average: 45.01%
- Percentile against its own history: 94th
- Range: 10.13% – 81.68% across 237 sessions with a reading

Over the last 20 sessions RUBICON settled 53.0% of its traded quantity, which is above average for an NSE equity. Its one-year average is 45.0%, so recent sessions are running 8.0 points higher than usual.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 26,806.2 crore
- P/E (TTM): 93.01 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 17.41 INR, split-adjusted to match the price series
- Revenue growth: — YoY, 3.97% QoQ
- Profit growth: — YoY, 10.41% QoQ

## Quarterly results

Last 4 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2025-09-30 | 412 | 341 | 71.7 | 53.9 | 3.49 | 13.07% |
| 2025-12-31 | 475.5 | 388.7 | 90.6 | 72.8 | 4.46 | 15.31% |
| 2026-03-31 | 513.9 | 417.8 | 98.7 | 76.8 | 4.66 | 14.94% |
| 2026-06-30 | 534.3 | 429.6 | 110.4 | 84.8 | 5.13 | 15.87% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 59.76%
- Public: 40.24%
- FII: 7.52%, DII: 9.43%
- Promoter shares pledged: 0%

## Recent filings

- 2026-08-14: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_187402_14082026172814_iXBRL_WEB.html
- 2026-08-07: dividend
- 2026-07-18: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1696024_18072026021120_WEB.xml
- 2026-05-29: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_163965_29052026193447_iXBRL_WEB.html
- 2026-04-21: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1655712_21042026104425_WEB.xml
- 2026-02-03: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_139935_03022026184018_iXBRL_WEB.html
- 2026-01-21: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1606618_21012026120123_WEB.xml
- 2025-11-13: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_127541_13112025201013_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 9 events are indexed for this instrument.

## About the instrument

- Listed: 2025-10-16 — latest session 2026-09-30 (237 sessions)
- ISIN: INE506V01022
- Series: EQ
- Liquidity rank: #495 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/RUBICON.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.